Sudden Cardiac Arrest and Death in Sports: An Updated Overview of Epidemiology, Etiologies, and Prevention Strategies, with Emphasis on Inherited Cardiomyopathies.

IF 4.1 2区 医学 Q2 HEMATOLOGY
Giorgia Beffagna, Fabian Sanchis-Gomar, Flavio Ribichini, Giuseppe Lippi
{"title":"Sudden Cardiac Arrest and Death in Sports: An Updated Overview of Epidemiology, Etiologies, and Prevention Strategies, with Emphasis on Inherited Cardiomyopathies.","authors":"Giorgia Beffagna, Fabian Sanchis-Gomar, Flavio Ribichini, Giuseppe Lippi","doi":"10.1055/a-2664-0950","DOIUrl":null,"url":null,"abstract":"<p><p>Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) in sports, although rare, remain pressing concerns with rising global participation in athletics. Recent epidemiological analyses indicate that incidence of SCA/SCD in athletes is low and has remained relatively stable over the past two decades. However, outcomes have improved as survival rates increase, reflecting advances in emergency response. Key risk factors are well-established, such as male athletes face a markedly higher risk than females, older master athletes have higher SCD risk rates than those under 35 years (largely due to acquired coronary artery disease), and certain high-intensity sports (e.g., basketball, American football, soccer, and endurance exercise) present higher SCA/SCD risk. In young competitive athletes, most SCDs are a consequence of undetected hereditary or congenital heart disorders. Predominant causes in this group include structural cardiomyopathies, such as hypertrophic cardiomyopathy and arrhythmogenic cardiomyopathy, and primary electrical diseases (channelopathies like long QT syndrome, Brugada syndrome, or catecholaminergic polymorphic ventricular tachycardia). Contrarily, occult atherosclerotic coronary disease becomes the leading cause of fatal events in master athletes. Multifaceted prevention strategies have expanded in recent years. Pre-participation cardiac screening programs aim to detect at-risk individuals and have successfully prevented SCD. Equally important, widespread implementation of emergency action plans, including on-site automated external defibrillators and cardiopulmonary resuscitation training, has improved resuscitation outcomes. Heightened public awareness, prompted by high-profile on-field cardiac arrests, has catalyzed policy changes that mandate better cardiac screening and emergency preparedness. Collectively, these efforts are shaping a safer sporting environment and reducing the SCA/SCD risk in athletes.</p>","PeriodicalId":21673,"journal":{"name":"Seminars in thrombosis and hemostasis","volume":" ","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in thrombosis and hemostasis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2664-0950","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) in sports, although rare, remain pressing concerns with rising global participation in athletics. Recent epidemiological analyses indicate that incidence of SCA/SCD in athletes is low and has remained relatively stable over the past two decades. However, outcomes have improved as survival rates increase, reflecting advances in emergency response. Key risk factors are well-established, such as male athletes face a markedly higher risk than females, older master athletes have higher SCD risk rates than those under 35 years (largely due to acquired coronary artery disease), and certain high-intensity sports (e.g., basketball, American football, soccer, and endurance exercise) present higher SCA/SCD risk. In young competitive athletes, most SCDs are a consequence of undetected hereditary or congenital heart disorders. Predominant causes in this group include structural cardiomyopathies, such as hypertrophic cardiomyopathy and arrhythmogenic cardiomyopathy, and primary electrical diseases (channelopathies like long QT syndrome, Brugada syndrome, or catecholaminergic polymorphic ventricular tachycardia). Contrarily, occult atherosclerotic coronary disease becomes the leading cause of fatal events in master athletes. Multifaceted prevention strategies have expanded in recent years. Pre-participation cardiac screening programs aim to detect at-risk individuals and have successfully prevented SCD. Equally important, widespread implementation of emergency action plans, including on-site automated external defibrillators and cardiopulmonary resuscitation training, has improved resuscitation outcomes. Heightened public awareness, prompted by high-profile on-field cardiac arrests, has catalyzed policy changes that mandate better cardiac screening and emergency preparedness. Collectively, these efforts are shaping a safer sporting environment and reducing the SCA/SCD risk in athletes.

运动中的心脏骤停和死亡:流行病学、病因学和预防策略的最新综述,重点是遗传性心肌病。
体育运动中的心脏骤停(SCA)和心脏性猝死(SCD)虽然罕见,但随着全球体育运动参与度的提高,它们仍然是人们迫切关注的问题。最近的流行病学分析表明,运动员SCA/SCD发病率较低,在过去二十年中保持相对稳定。然而,随着存活率的提高,结果有所改善,这反映了应急反应的进步。关键的危险因素已经确定,例如男性运动员的风险明显高于女性,年龄较大的优秀运动员的SCD风险率高于35岁以下的运动员(主要是由于获得性冠状动脉疾病),某些高强度运动(如篮球、橄榄球、足球和耐力运动)存在更高的SCA/SCD风险。在年轻的竞技运动员中,大多数scd是未被发现的遗传性或先天性心脏病的结果。本组的主要病因包括结构性心肌病,如肥厚性心肌病和致心律失常性心肌病,以及原发性电性疾病(通道病,如长QT综合征、Brugada综合征或儿茶酚胺能多形性室性心动过速)。相反,隐匿性动脉粥样硬化性冠状动脉疾病成为优秀运动员死亡事件的主要原因。近年来扩大了多方面的预防战略。参与前心脏筛查项目旨在发现高危人群并成功预防SCD。同样重要的是,广泛实施紧急行动计划,包括现场自动体外除颤器和心肺复苏培训,改善了复苏结果。由于现场发生了引人注目的心脏骤停,提高了公众意识,促使政策发生变化,要求更好地进行心脏筛查和应急准备。总的来说,这些努力正在塑造一个更安全的运动环境,并降低运动员的SCA/SCD风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Seminars in thrombosis and hemostasis
Seminars in thrombosis and hemostasis 医学-外周血管病
CiteScore
8.80
自引率
21.10%
发文量
132
审稿时长
6-12 weeks
期刊介绍: Seminars in Thrombosis and Hemostasis is a topic driven review journal that focuses on all issues relating to hemostatic and thrombotic disorders. As one of the premiere review journals in the field, Seminars in Thrombosis and Hemostasis serves as a comprehensive forum for important advances in clinical and laboratory diagnosis and therapeutic interventions. The journal also publishes peer reviewed original research papers. Seminars offers an informed perspective on today''s pivotal issues, including hemophilia A & B, thrombophilia, gene therapy, venous and arterial thrombosis, von Willebrand disease, vascular disorders and thromboembolic diseases. Attention is also given to the latest developments in pharmaceutical drugs along with treatment and current management techniques. The journal also frequently publishes sponsored supplements to further highlight emerging trends in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信